Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.

Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, Xiong Y.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1392-7.

2.
4.

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.

Waga S, Hannon GJ, Beach D, Stillman B.

Nature. 1994 Jun 16;369(6481):574-8.

PMID:
7911228
5.

Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.

Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG.

Circulation. 2000 May 2;101(17):2022-5.

6.
7.

Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta.

Ducoux M, Urbach S, Baldacci G, Hübscher U, Koundrioukoff S, Christensen J, Hughes P.

J Biol Chem. 2001 Dec 28;276(52):49258-66. Epub 2001 Oct 10.

8.
9.
10.
11.

Myc and the cell cycle.

Amati B, Alevizopoulos K, Vlach J.

Front Biosci. 1998 Feb 15;3:d250-68. Review.

PMID:
9468463
12.

p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells.

Cayrol C, Knibiehler M, Ducommun B.

Oncogene. 1998 Jan 22;16(3):311-20.

13.

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.

Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ.

Genes Dev. 1995 Mar 15;9(6):650-62.

15.

New functional activities for the p21 family of CDK inhibitors.

LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E.

Genes Dev. 1997 Apr 1;11(7):847-62.

16.

Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.

Luo Y, Hurwitz J, Massagué J.

Nature. 1995 May 11;375(6527):159-61.

PMID:
7753174
17.

Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.

Yan Y, Frisén J, Lee MH, Massagué J, Barbacid M.

Genes Dev. 1997 Apr 15;11(8):973-83.

18.

Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.

Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS.

Oncogene. 1998 Apr 23;16(16):2141-50.

19.

Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors.

Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee MH, Gerald WL, Massagué J, Weissman BE, Cordón-Cardó C.

Cancer Res. 1996 Mar 15;56(6):1219-21.

20.

Supplemental Content

Support Center